Cargando…

Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs

Induced pluripotent stem cells (iPSCs) have shown promise in investigating donor‐specific phenotypes and pathologies. The iPSC‐derived cardiomyocytes (iPSC‐CMs) could potentially be utilized in personalized cardiotoxicity studies, assessing individual proarrhythmic risk. However, it is unclear how c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blinova, Ksenia, Schocken, Derek, Patel, Dakshesh, Daluwatte, Chathuri, Vicente, Jose, Wu, Joseph C., Strauss, David G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853144/ https://www.ncbi.nlm.nih.gov/pubmed/31328865 http://dx.doi.org/10.1111/cts.12674

Ejemplares similares

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
por: Tran, Phu N., et al.
Publicado: (2020)

“Thorough QT/QTc in a Dish”: Can Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Predict Thorough QT Outcomes?
por: Vargas, Hugo M.
Publicado: (2019)

QT prolongation in the STREAM Stage 1 Trial
por: Hughes, G., et al.
Publicado: (2022)

Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
por: Narkar, Akshay, et al.
Publicado: (2022)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
por: Rowe, Elizabeth J., et al.
Publicado: (2022)

A framework to characterize the performance of early warning index alarm systems for patient monitoring
por: Daluwatte, Chathuri, et al.
Publicado: (2019)

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
por: Shinozawa, Tadahiro, et al.
Publicado: (2017)

Predicting potential adverse events using safety data from marketed drugs
por: Daluwatte, Chathuri, et al.
Publicado: (2020)

Managing drug-induced QT prolongation in clinical practice
por: Khatib, Rani, et al.
Publicado: (2021)

COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm
por: Gollob, Michael H.
Publicado: (2020)

Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development
por: Fermini, Bernard, et al.
Publicado: (2018)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
por: Wiśniowska, Barbara, et al.
Publicado: (2016)

Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations
por: Voronova, Veronika, et al.
Publicado: (2021)

Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes
por: Sleiman, Yvonne, et al.
Publicado: (2023)

Antipsychotic Medication and QT Prolongation
por: Chohan, Paramdip Singh, et al.
Publicado: (2015)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
por: Singleton, Matthew J., et al.
Publicado: (2020)

Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation
por: Ranjan, Amalendu P, et al.
Publicado: (2013)

Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
por: Feaster, Tromondae K., et al.
Publicado: (2021)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

QT Prolongation due to Graves' Disease
por: Kulairi, Zain, et al.
Publicado: (2017)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Trousseau’s sign and QT prolongation in hypocalcaemia
por: Schnur, Jack, et al.
Publicado: (2021)

Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
por: Eschenhagen, Thomas, et al.
Publicado: (2015)

Cardiomyocyte Deletion of Bmal1 Exacerbates QT- and RR-Interval Prolongation in Scn5a(+/ΔKPQ) Mice
por: Schroder, Elizabeth A., et al.
Publicado: (2021)

KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation
por: Song, Yuanxiu, et al.
Publicado: (2022)

Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment
por: Koo, Yeryung, et al.
Publicado: (2023)

Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
por: Casciola, Maura, et al.
Publicado: (2022)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Characterizing QT interval prolongation in early clinical development: a case study with methadone
por: Dubois, Vincent F. S., et al.
Publicado: (2017)

Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for “Clinical Trials in a Dish”
por: Kumar, Naresh, et al.
Publicado: (2020)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

A Case of QT Prolongation Associated with Panhypopituitarism
por: Arpaci, Dilek, et al.
Publicado: (2013)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

Energy Drinks: Another Cause of QT Prolongation?
por: Winniford, Michael D.
Publicado: (2019)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g92fsvurke4tteh8gtj0cjmo5d